• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Passage Bio Inc (NQ: PASG )

    0.9160 +0.0243 (+2.73%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20,844
    Open 0.9100
    Bid (Size) 0.8703 (10)
    Ask (Size) 1.020 (4)
    Prev. Close 0.8917
    Today's Range 0.9000 - 0.9379
    52wk Range 0.5751 - 1.790
    Shares Outstanding 61,640,596
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
    From Passage Bio
    Via GlobeNewswire
    PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024
    PASG stock results show that Passage Bio beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +1.65%
    +1.65%
    1 Month
    -27.30%
    -27.30%
    3 Month
    -35.94%
    -35.94%
    6 Month
    -1.19%
    -1.19%
    1 Year
    +1.62%
    +1.62%

    More News

    Read More
    Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
    From Passage Bio
    Via GlobeNewswire
    Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
    From Passage Bio
    Via GlobeNewswire
    Recap: Passage Bio Q3 Earnings
    Via Benzinga
    PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023
    Via InvestorPlace
    Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
    From Passage Bio
    Via GlobeNewswire
    Passage Bio to Participate in Upcoming Investor Conferences
    From Passage Bio
    Via GlobeNewswire
    7 Analyst-Backed Stocks With Promising 10-Bagger Potential
    Via InvestorPlace
    Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    From Passage Bio
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
    From Passage Bio
    Via GlobeNewswire
    Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
    From Passage Bio
    Via GlobeNewswire
    Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
    From Passage Bio
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
    From Passage Bio
    Via GlobeNewswire
    Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Passage Bio
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.